RT @EUScienceInnov: Addressing the needs of Young #Cancersurvivors is an EU #MissionCancer priority!
For the 1st time, we're organising an event to give them the chance to share their experiences and interact with each other.
Join us and be an integral part of this conference on 7 February! 👇
🐦🔗: https://n.respublicae.eu/EMA_News/status/1612409224038076422
#MedicalDevices | Last Friday we have proposed a revised regulatory timeline to:
🔸enable industry to continue producing essential medical devices
🔸reduce any short-term risk of shortages
🔸safeguard access for patients most in need
#HealthUnion
RT @EU_Health: Medical Devices Regulation: Despite considerable progress on implementation, the transition to the new rules is slower than anticipated.
Today we're proposing legislation that will support ongoing efforts…
🐦🔗: https://n.respublicae.eu/EU_Health/status/1612370530044370944
#ECDC assessment of the XBB.1.5 sub-lineage.
(...) This variant could have an increasing effect on the number of #COVID19 cases in the EU/EEA, but not within the coming month as it is currently only present in the EU/EEA at very low levels. (...)
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1611041382520471552
Given the rapidly developing #COVID19 situation in China and a lack of reliable data, the #EUHealthSecurity Committee has issued an opinion emphasising the need for a common, phased & proportionate response, following the IPCR
Text here: https://europa.eu/!DmTCcT
#HealthUnion
1/3
🐦🔗: https://n.respublicae.eu/EU_Health/status/1610952637754531841
#COVID19 is virus that evolves quickly and unpredictably.
Yet, we know that vaccination and booster doses are safe.
They also continue to protect people from severe, hospitalisation and death.
Take a moment to check you are fully protected, as per your national recommendations.
🐦🔗: https://n.respublicae.eu/EU_Health/status/1610603050821095424
Check out the latest reports and studies funded under the 3rd health programme - you will learn more about:
🔵 EU vaccination card
🔵 Public procurement of #medicines
🔵 Pricing policies on food and beverages
...and other #PublicHealth topics!
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1610591649331036160
Today 🇪🇺 Health Security Committee converged on action including:
▶️Pre-departure testing for travellers from China
▶️Stepped up wastewater monitoring
▶️Increased domestic surveillance
Discussion continues tomorrow in IPCR.
🇪🇺 unity remains our strongest tool against COVID.
🐦🔗: https://n.respublicae.eu/SKyriakidesEU/status/1610314734137393153
Also in 2⃣0⃣2⃣3⃣: #EU4Health will remain our biggest-ever investment in public health.
With a budget of EUR 735,8 million, it will allow for swift progress on priority actions linked to further development of the EU #HealthUnion
Have a look at this year's work programme ⬇
🐦🔗: https://n.respublicae.eu/EU_Health/status/1610539149836124162
Are you looking for funding opportunities to support your ideas on #CancerResearch?
📌Don't miss the the Info Days to learn about the new topics and calls under the #EUCancerMission
🗓️17 - 18 January 2023
https://research-innovation-community.ec.europa.eu/events/1nVczf9ihgPdOg3zyoLyuC/overview
🐦🔗: https://n.respublicae.eu/EU_HaDEA/status/1610557005692821504
#JustPublished!
Impact of surge in China #COVID19 cases on epidemiological situation in EU/EEA.
The number of cases has reached a record high in China, peaking on 2.12.22. In the past three weeks, incidence has fallen, likely also due to a lower testing.
https://www.ecdc.europa.eu/en/news-events/impact-surge-china-covid-19-cases
🐦🔗: https://n.respublicae.eu/ECDC_EU/status/1610196071971528704
EU countries agreed on a coordinated approach to the changing #COVID19 situation at today's #EUHealthSecurity Committee meeting, including implications for increased travel from China.
This feeds into tomorrow's integrated political crisis response (IPCR) meeting
🐦🔗: https://n.respublicae.eu/EU_Health/status/1610317577825157121
As of 🗓️31 January 2023, #ClinicalTrial sponsor will have to use the Clinical Trials Information System and follow the same process to apply for the authorisation of a clinical trial in the #EEA.
Learn more from the video 👇
🐦🔗: https://n.respublicae.eu/EMA_News/status/1608770746934874113
Only a month ago we've adopted our new #EUGlobalHealthStrategy to:
🔸deliver better health for all
🔸strengthen health systems & advance universal health coverage
🔸prevent & combat health threats, applying a #OneHealth approach
#GlobalGateway #HealthUnion
#ThrowbackThursday
🐦🔗: https://n.respublicae.eu/EU_Health/status/1608364822420226048
RT @hans_kluge: 4/
Living with COVID is our long-term global reality.
The virus will continue to change with new variants possible.
We can safeguard ourselves and those around us via sensible personal hygiene & protective measures - including getting vaccinated, particularly the vulnerable.
🐦🔗: https://n.respublicae.eu/EMA_News/status/1608753440129445892
The pandemic had a dramatic impact on people’s lives around the world.
In 2019-2021, COVID-19 has reduced life expectancy in almost all European countries.
Download the full 'Health at a Glance: Europe 2022'-report:
https://europa.eu/!fwx6XQ
#HealthUnion #SoHEU22
@OECD_Social
🐦🔗: https://n.respublicae.eu/EU_Health/status/1608727084091727872
Are you an academic sponsor 🎓 or a non-profit organisation developing advanced therapy medicines? Are you seeking regulatory support? 💊💉
Join EMA’s pilot for European academic and non-profit developers of advanced therapy medicinal products (#ATMPs).
🐦🔗: https://n.respublicae.eu/EMA_News/status/1608462844097429509
EMA has approved 8⃣6⃣ biosimilars that help treating serious diseases such as #diabetes and #cancer.
All EU-approved 🇪🇺 biosimilars are interchangeable with their reference medicine or an equivalent biosimilar ✅
Read more!
🐦🔗: https://n.respublicae.eu/EMA_News/status/1608077933293309954
Entering into force TODAY!
We are building a stronger 🇪🇺 #HealthUnion, including:
✅New Serious Cross-Border Health Threats Regulation
✅Extended mandate for @ECDC_EU
✅New Emergency Framework Regulation
Further strengthening our #EUHealthSecurity legal framework
🐦🔗: https://n.respublicae.eu/EU_Health/status/1606986562109071361
#COVID19vaccines: Where do we stand?
✅ 7 authorisations completed
✅ 4 #AdaptedVaccines approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5
#VaccinesWork #UnitedinProtection
🐦🔗: https://n.respublicae.eu/EMA_News/status/1606201703145127936
Are you a clinical trial sponsor? With the Clinical Trials Information System, you will be able to apply for authorisations in up to 30 EU/EEA countries through a single application.
There is a transition period for this. Learn more! #ClinicalTrials #EU
🐦🔗: https://n.respublicae.eu/EMA_News/status/1605884416764559361
Unofficial automated mirror. No copyright asserted. ∎ Latest news from the European Medicines Agency, the European Union agency responsible for the evaluation and supervision of medicines. RTs ≠ endorsement.